Prestige Consumer Healthcare (PBH) Competitors

Prestige Consumer Healthcare (NYSE:PBH) and Interparfums (NASDAQ:IPAR) are both mid-cap personal products companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment.

Do analysts rate PBH or IPAR?

Prestige Consumer Healthcare presently has a consensus price target of $96.80, indicating a potential upside of 53.71%. Interparfums has a consensus price target of $162.00, indicating a potential upside of 58.87%. Given Interparfums' stronger consensus rating and higher probable upside, analysts plainly believe Interparfums is more favorable than Prestige Consumer Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prestige Consumer Healthcare	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Interparfums	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more risk and volatility, PBH or IPAR?

Prestige Consumer Healthcare has a beta of 0.46, meaning that its share price is 54% less volatile than the S&P 500. Comparatively, Interparfums has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500.

Does the media refer more to PBH or IPAR?

In the previous week, Prestige Consumer Healthcare had 15 more articles in the media than Interparfums. MarketBeat recorded 16 mentions for Prestige Consumer Healthcare and 1 mentions for Interparfums. Interparfums' average media sentiment score of 1.42 beat Prestige Consumer Healthcare's score of 0.53 indicating that Interparfums is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prestige Consumer Healthcare	5 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Interparfums	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is PBH or IPAR a better dividend stock?

Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 3.0%. Interparfums pays an annual dividend of $3.20 per share and has a dividend yield of 3.1%. Prestige Consumer Healthcare pays out 44.6% of its earnings in the form of a dividend. Interparfums pays out 64.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Interparfums has increased its dividend for 4 consecutive years. Interparfums is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Is PBH or IPAR more profitable?

Prestige Consumer Healthcare has a net margin of 19.02% compared to Interparfums' net margin of 11.03%. Interparfums' return on equity of 16.45% beat Prestige Consumer Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prestige Consumer Healthcare	19.02%	12.69%	6.79%
Interparfums	11.03%	16.45%	11.14%

Do institutionals and insiders believe in PBH or IPAR?

99.9% of Prestige Consumer Healthcare shares are held by institutional investors. Comparatively, 55.6% of Interparfums shares are held by institutional investors. 1.4% of Prestige Consumer Healthcare shares are held by company insiders. Comparatively, 43.7% of Interparfums shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Which has higher valuation and earnings, PBH or IPAR?

Prestige Consumer Healthcare has higher earnings, but lower revenue than Interparfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prestige Consumer Healthcare	$1.12B	2.77	$214.60M	$4.26	14.78
Interparfums	$1.46B	2.24	$164.36M	$4.99	20.43

Summary

Interparfums beats Prestige Consumer Healthcare on 13 of the 19 factors compared between the two stocks.